Home Healthcare Medical Devices Artificial Lung Market

Artificial Lung Market Size, Share & Trends Analysis Report By Product Type (Extracorporeal Membrane Oxygenation (ECMO) Systems, Paracorporeal Artificial Lungs, Intracorporeal Artificial Lungs, Membrane Oxygenators, Portable Artificial Lungs), By Application (Bridge-to-Transplantation, Bridge-to-Recovery, ECMO-assisted Ventilation, Pulmonary Rehabilitation, Long-term Support for Chronic Lung Diseases), By End User (Tertiary Care Hospitals, Transplant Centers, Research Institutions and Clinical Trial Sites, Specialty Respiratory Clinics) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Artificial Lung Market, By Product Type 2022-2034 (USD MILLION/ Units)
    1. Extracorporeal Membrane Oxygenation (ECMO) Systems
    2. Paracorporeal Artificial Lungs
    3. Intracorporeal Artificial Lungs
    4. Membrane Oxygenators
    5. Portable Artificial Lungs
  2. Artificial Lung Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Bridge-to-Transplantation
    2. Bridge-to-Recovery
    3. ECMO-assisted Ventilation
    4. Pulmonary Rehabilitation
    5. Long-term Support for Chronic Lung Diseases
  3. Artificial Lung Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Tertiary Care Hospitals
    2. Transplant Centers
    3. Research Institutions and Clinical Trial Sites
    4. Specialty Respiratory Clinics
  4. Regional Artificial Lung Market
    1. North America
      1. North America Artificial Lung Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
      2. North America Artificial Lung Market By Application 2022-2034 (USD MILLION/ Units)
        1. Bridge-to-Transplantation
        2. Bridge-to-Recovery
        3. ECMO-assisted Ventilation
        4. Pulmonary Rehabilitation
        5. Long-term Support for Chronic Lung Diseases
      3. North America Artificial Lung Market By End User 2022-2034 (USD MILLION/ Units)
        1. Tertiary Care Hospitals
        2. Transplant Centers
        3. Research Institutions and Clinical Trial Sites
        4. Specialty Respiratory Clinics
      4. U.S.
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      5. Canada
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
    2. Europe
      1. Europe Artificial Lung Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
      2. Europe Artificial Lung Market By Application 2022-2034 (USD MILLION/ Units)
        1. Bridge-to-Transplantation
        2. Bridge-to-Recovery
        3. ECMO-assisted Ventilation
        4. Pulmonary Rehabilitation
        5. Long-term Support for Chronic Lung Diseases
      3. Europe Artificial Lung Market By End User 2022-2034 (USD MILLION/ Units)
        1. Tertiary Care Hospitals
        2. Transplant Centers
        3. Research Institutions and Clinical Trial Sites
        4. Specialty Respiratory Clinics
      4. U.K.
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      5. Germany
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      6. France
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      7. Spain
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      8. Italy
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      9. Russia
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      10. Nordic
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      11. Benelux
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      12. Rest of Europe
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
    3. APAC
      1. APAC Artificial Lung Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
      2. APAC Artificial Lung Market By Application 2022-2034 (USD MILLION/ Units)
        1. Bridge-to-Transplantation
        2. Bridge-to-Recovery
        3. ECMO-assisted Ventilation
        4. Pulmonary Rehabilitation
        5. Long-term Support for Chronic Lung Diseases
      3. APAC Artificial Lung Market By End User 2022-2034 (USD MILLION/ Units)
        1. Tertiary Care Hospitals
        2. Transplant Centers
        3. Research Institutions and Clinical Trial Sites
        4. Specialty Respiratory Clinics
      4. China
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      5. Korea
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      6. Japan
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      7. India
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      8. Australia
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      9. Taiwan
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      10. South East Asia
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      11. Rest of Asia-Pacific
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
    4. Middle East and Africa
      1. Middle East and Africa Artificial Lung Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
      2. Middle East and Africa Artificial Lung Market By Application 2022-2034 (USD MILLION/ Units)
        1. Bridge-to-Transplantation
        2. Bridge-to-Recovery
        3. ECMO-assisted Ventilation
        4. Pulmonary Rehabilitation
        5. Long-term Support for Chronic Lung Diseases
      3. Middle East and Africa Artificial Lung Market By End User 2022-2034 (USD MILLION/ Units)
        1. Tertiary Care Hospitals
        2. Transplant Centers
        3. Research Institutions and Clinical Trial Sites
        4. Specialty Respiratory Clinics
      4. UAE
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      5. Turkey
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      6. Saudi Arabia
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      7. South Africa
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      8. Egypt
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      9. Nigeria
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      10. Rest of MEA
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
    5. LATAM
      1. LATAM Artificial Lung Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
      2. LATAM Artificial Lung Market By Application 2022-2034 (USD MILLION/ Units)
        1. Bridge-to-Transplantation
        2. Bridge-to-Recovery
        3. ECMO-assisted Ventilation
        4. Pulmonary Rehabilitation
        5. Long-term Support for Chronic Lung Diseases
      3. LATAM Artificial Lung Market By End User 2022-2034 (USD MILLION/ Units)
        1. Tertiary Care Hospitals
        2. Transplant Centers
        3. Research Institutions and Clinical Trial Sites
        4. Specialty Respiratory Clinics
      4. Brazil
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      5. Mexico
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      6. Argentina
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      7. Chile
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      8. Colombia
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
      9. Rest of LATAM
        1. Extracorporeal Membrane Oxygenation (ECMO) Systems
        2. Paracorporeal Artificial Lungs
        3. Intracorporeal Artificial Lungs
        4. Membrane Oxygenators
        5. Portable Artificial Lungs
        6. Bridge-to-Transplantation
        7. Bridge-to-Recovery
        8. ECMO-assisted Ventilation
        9. Pulmonary Rehabilitation
        10. Long-term Support for Chronic Lung Diseases
        11. Tertiary Care Hospitals
        12. Transplant Centers
        13. Research Institutions and Clinical Trial Sites
        14. Specialty Respiratory Clinics
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.